Revealing second messenger functions in bacterial stress response, cell differentiation and natural product biosynthesis
This project aims to explore c-di-AMP functions in Streptomyces to uncover new bacterial signaling principles and identify potential antibiotic targets and biosynthesis triggers.
Projectdetails
Introduction
Sophisticated signalling systems enable bacteria to occupy almost every single niche on our planet. In such systems, second messengers are crucial information carriers that elicit cellular adaptation to diverse signals. Current dynamics in signalling research have led to the discovery of an exquisite collection of nucleotides that bacteria use as second messengers, including cyclic dimeric adenosine monophosphate (c-di-AMP). A unique feature of c-di-AMP is its essentiality, making it an attractive target for antibiotics.
Objectives
The main objective of this proposal is to uncover the full repertoire of c-di-AMP functions and metabolism in bacteria by using Streptomyces as a model.
Model Organism
Streptomyces are our most prolific antibiotic producers and represent an excellent system to study multicellular differentiation. They live in soil, where they encounter diverse environmental cues that trigger antibiotic production and a complex transition from multicellular filaments to spores.
Role of c-di-AMP
c-di-AMP enables Streptomyces to survive osmotic stress caused by rainfall and drought, but interferes with development. How c-di-AMP affects differentiation and how these bacteria adapt to stress signalled by c-di-AMP is unknown.
Proposed Research
Here, we propose that bacteria use a novel transmembrane signalling pathway to remodel their cell wall for surviving stress mediated by c-di-AMP.
Challenging Current Views
We will challenge the current view in the field by showing that the set of enzymes involved in c-di-AMP dynamics is larger than it is currently believed and we will identify new c-di-AMP effectors.
Exploration of c-di-AMP
Finally, we will explore the potential of c-di-AMP for manipulation of natural product biosynthesis and address the function of a linear di-AMP molecule that is new to signalling research.
Impact
Our proposed research will not only lead to the discovery of fundamental new principles in bacterial signalling and differentiation but might also identify new cell wall associated targets for drug design and tools for triggering antibiotic biosynthesis.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.478.373 |
Totale projectbegroting | € 1.478.373 |
Tijdlijn
Startdatum | 1-7-2022 |
Einddatum | 30-6-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- GOTTFRIED WILHELM LEIBNIZ UNIVERSITAET HANNOVERpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Unraveling the regulatory networks in Streptomyces that switch on antibiotic production on demandThis project aims to unlock the expression of cryptic biosynthetic gene clusters in Streptomyces to enhance drug discovery and agricultural applications through innovative systems biology and ecological insights. | ERC Advanced... | € 3.343.206 | 2022 | Details |
Cyclic nucleotides as second messengers in plantsThis project aims to establish cAMP and cGMP as key second messengers in plant signaling by developing optogenetic tools to manipulate their levels and explore their roles in various pathways. | ERC Advanced... | € 2.499.706 | 2024 | Details |
Scalable Microbial Metabolite Discovery Through Synthetic BiologyThis project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development. | ERC Starting... | € 1.490.250 | 2024 | Details |
Reassessing Bacterial Cell Cycle Regulation: Revealing Novel Regulatory Principles in Realistic EnvironmentsThis project aims to investigate the bacterial cell cycle of Streptococcus pneumoniae under clinically relevant stresses to identify new antimicrobial targets against antibiotic resistance. | ERC Starting... | € 1.499.926 | 2025 | Details |
A new framework to interrogate molecular mechanisms mediating antagonistic diatom-bacteria interactionsDIACIDAL aims to uncover the mechanisms of bacterial pathogenicity towards diatoms and their defense responses, enhancing understanding of oceanic carbon fluxes and potential biotechnological applications. | ERC Consolid... | € 2.299.893 | 2025 | Details |
Unraveling the regulatory networks in Streptomyces that switch on antibiotic production on demand
This project aims to unlock the expression of cryptic biosynthetic gene clusters in Streptomyces to enhance drug discovery and agricultural applications through innovative systems biology and ecological insights.
Cyclic nucleotides as second messengers in plants
This project aims to establish cAMP and cGMP as key second messengers in plant signaling by developing optogenetic tools to manipulate their levels and explore their roles in various pathways.
Scalable Microbial Metabolite Discovery Through Synthetic Biology
This project aims to enhance the discovery of microbial secondary metabolites by developing a scalable heterologous expression platform to access untapped biosynthetic genes for drug development.
Reassessing Bacterial Cell Cycle Regulation: Revealing Novel Regulatory Principles in Realistic Environments
This project aims to investigate the bacterial cell cycle of Streptococcus pneumoniae under clinically relevant stresses to identify new antimicrobial targets against antibiotic resistance.
A new framework to interrogate molecular mechanisms mediating antagonistic diatom-bacteria interactions
DIACIDAL aims to uncover the mechanisms of bacterial pathogenicity towards diatoms and their defense responses, enhancing understanding of oceanic carbon fluxes and potential biotechnological applications.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Pharmaco-modulation of epithelia for induction of antimicrobial peptide expression: a disruptive approach to fight antibiotic resistanceMaxImmun aims to develop innovative molecules that enhance antimicrobial peptides to combat infections and antibiotic resistance, progressing towards clinical trials. | EIC Pathfinder | € 3.194.450 | 2024 | Details |
Pharmaco-modulation of epithelia for induction of antimicrobial peptide expression: a disruptive approach to fight antibiotic resistance
MaxImmun aims to develop innovative molecules that enhance antimicrobial peptides to combat infections and antibiotic resistance, progressing towards clinical trials.